MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Gastroenterology

Section

Gastroenterology

642 articles

Ask AI
All specialtiesGastroenterologynewsClinical UpdatesCardiologyOncology
Transplantation

Rising Trends and Outcomes of MASLD in Liver Transplantation: Implications for Early Detection and Management

MASLD has become a leading cause of liver transplantation in the US, with increasing transplant volumes and younger recipients. Despite relative stabilization in growth, survival post-transplant has improved, highlighting evolving epidemiol

MedXY Editorial Team
Nov 5, 2026

Latest updates

Gastroenterology

A Novel Endoscopic Classification Predicts Fundoplication Integrity and Pathologic Reflux After Antireflux Surgery

This study develops and prospectively validates a simple endoscopic classification of fundoplication integrity that reliably predicts pathological gastroesophageal reflux post-antireflux surgery, correlating with functional and clinical out

Nov 5, 2026
Gastroenterology

Evolving Patterns and Outcomes of Idiosyncratic Drug-Induced Liver Injury in the U.S.: Insights from the 20-Year DILIN Prospective Registry

Analysis of 1,983 high-certainty DILI cases over two decades reveals shifting drug causes, declining severity, increased herbal and oncology-related cases, and higher mortality among elderly, patients with chronic liver disease, and oncolog

Nov 5, 2026
Gastroenterology

Days at Home After Gastrointestinal Cancer Surgery: Validating a Patient-Centered Outcome Metric

This review synthesizes evidence establishing Days at Home within 90 days (DAH-90) after gastrointestinal cancer surgery as a valid, meaningful patient-centered outcome, integrating survival, morbidity, and healthcare utilization to optimiz

Nov 4, 2026
Oncology

Derazantinib in FGFR2-Altered Intrahepatic Cholangiocarcinoma: Promising Phase 2 Efficacy with Manageable Toxicity

A pivotal Phase 2 study demonstrates that derazantinib yields meaningful responses and progression-free survival in FGFR2-aberrant advanced intrahepatic cholangiocarcinoma, with an acceptable safety profile, supporting its role as a targete

Nov 4, 2026
Transplantation

Serum LRG-1 and Citrulline Ratio: A Breakthrough Biomarker Duo for Intestinal Transplant Rejection Monitoring

Combining serum leucine-rich alpha-2-glycoprotein 1 (LRG-1) with citrulline offers a sensitive, noninvasive biomarker strategy for early detection and monitoring of rejection in intestinal transplantation, potentially reducing reliance on i

Nov 3, 2026
Gastroenterology

Comparative Efficacy of Subtotal Versus Total Colectomy for Slow-Transit Constipation: Insights from the STOPS Randomized Clinical Trial

The STOPS trial demonstrates noninferiority of subtotal colectomy with cecorectal anastomosis compared to total colectomy with ileorectal anastomosis for refractory slow-transit constipation at 1 year, balancing symptom relief with postoper

Nov 3, 2026
Gastroenterology

Dietary Intervention Lowers Intestinal Inflammation in High-Risk Relatives of Crohn’s Disease Patients: Insights from the PIONIR Trial

The PIONIR randomized crossover trial demonstrates that a specific Tasty&Healthy diet significantly reduces fecal calprotectin levels, a marker of gut inflammation, in first-degree relatives at high risk for Crohn’s disease, sugge

Nov 3, 2026
Gastroenterology

Saroglitazar in Primary Biliary Cholangitis: Insights from a Phase 2b/3 Adaptive Randomized Trial

Saroglitazar, a dual PPAR α/γ agonist, demonstrated significant biochemical improvement and ALP normalization in primary biliary cholangitis patients refractory or intolerant to UDCA, with favorable safety over 52 weeks in a phase 2b/3 tria

Nov 2, 2026
Gastroenterology

Linking Oral Health to Liver Cancer Risk: Insights from a Nationwide Swedish Cohort Study

A large Swedish cohort study reveals that dental diseases and tooth loss are associated with increased risk of primary liver cancer, highlighting the importance of oral health in systemic disease prevention.

Nov 1, 2026
General Surgery

Pancreatic Fistula and Intra-abdominal Fluid Collections After Distal Pancreatectomy: Incidence, Clinical Impact, and Management Strategies

This study analyzes the incidence and clinical consequences of pancreatic fistulas and intra-abdominal fluid collections following distal pancreatectomy, highlighting their management and the impact of surgical drain placement.

Nov 1, 2026
Gastroenterology

Miricorilant in Metabolic Dysfunction-Associated Steatohepatitis: Promising Phase 1b Results Highlight Intermittent Dosing Strategy

This phase 1b study of miricorilant, a selective glucocorticoid receptor modulator, shows significant reductions in liver fat and improvements in liver health markers in patients with presumed metabolic dysfunction-associated steatohepatiti

Nov 1, 2026
Oncology

Targeting Mevalonate Biosynthesis: A Novel Strategy Against Gemcitabine-resistant Pancreatic Cancer

This article explores how acquired resistance to gemcitabine in pancreatic cancer leads to metabolic reprogramming that creates a vulnerability in the mevalonate pathway, offering a promising therapeutic target.

Oct 31, 2026
Gastroenterology

Unveiling the Microbiota-Taurine Axis: Alginate Fiber’s Role in Promoting Mucosal Healing in Colitis

This article explores how dietary alginate fiber enhances mucosal healing through a microbiota-driven taurine pathway, evidenced by preclinical models and translational clinical insights in ulcerative colitis.

Oct 30, 2026
Neurology

Elevated Risk of Inflammatory Bowel Disease Following Anti-CD20 Therapy in Multiple Sclerosis Patients: Insights from a Swedish Population-Based Cohort

A Swedish cohort study reveals increased risk of inflammatory bowel disease in relapsing-remitting multiple sclerosis patients treated with rituximab compared to other therapies and the general population, underscoring the need for gastroin

Oct 30, 2026
Gastroenterology

Integrating Therapies for Alcohol Use Disorder in Alcohol-Associated Hepatitis Clinical Trials: Advancing Composite Endpoints for Improved Outcomes

Alcohol-associated hepatitis (AH) carries high morbidity and mortality, with no approved therapies addressing both liver injury and alcohol misuse. This article explores integrated trial designs using composite endpoints combining liver and

Oct 28, 2026
Gastroenterology

Driving Legislative Change for Access to Medications in Pediatric Inflammatory Bowel Disease

A pediatric IBD patient’s medication denial due to lack of pediatric FDA labeling prompted physician-led advocacy, resulting in a state law mandating insurance coverage for pediatric medications with adult approval and supporting data

Oct 28, 2026
Gastroenterology

Unveiling the Microbiome Landscape of Anastomotic Leaks After Foregut Surgery: Implications for Management and Outcomes

This study explores how microbiome compositions differ in patients with foregut anastomotic leaks managed endoscopically versus surgically, highlighting nutrition and microbial patterns as key factors influencing healing.

Oct 26, 2026
Gastroenterology

Bridging the Gap: Global Disparities in Liver Transplantation and Disease Burden (2000-2023)

This article analyzes global liver transplantation disparities relative to cirrhosis and chronic liver disease burden, revealing unequal access dominated by high-income countries and highlighting the role of health system development in tra

Oct 24, 2026
Gastroenterology

Optimizing Treatment Strategies for Gastric Cancer with Positive Peritoneal Cytology or Localized Peritoneal Metastasis

This article reviews a multicenter study comparing outcomes of different treatment approaches for gastric cancer patients with positive peritoneal cytology (CY1) and/or localized peritoneal metastasis (P1a), highlighting the superior surviv

Oct 22, 2026
1 / 25
123…25
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.